Is it possible to build a bridge between researchers and innovators of integrated care? by Schrijvers, Guus
1
International Journal of Integrated Care – Vol. 1, 1 September 2001 – ISSN 1568-4156 – http://www.ijic.org/
Editorial
Is it possible to build a bridge between researchers and
innovators of integrated care?
A tension exists between research and innovation of
integrated care. The first one asks for knowledge inde-
pendent of persons, location and time. The second
one often is driven by individual persons, on a favour-
able site and during an episode of a sense of urgency
that something is un-integrated in health services.
Mostly the first one is done within the scientific com-
munity. The last one is in the hand of pioneering man-
agers of health service institutes, often supported by
consultancy firms who deliver project managers and
knowledge on redesigning the core process.
In commercial firms research and development (R&D)
is much more integrated. For instance new equipment
is mostly based on research as well as on creative
inventions. In health services, two approaches for
innovations are popular now. The first one is learning
by doing (LBD), without any research. With this
approach many health care innovations are imple-
mented, as is shown by Van der Linden, whose book
is reviewed in this IJIC Issue. We mention also the
development of managed care in the United States
without too much research and with a lot of trial and
error (Robinson, book review in IJIC Issue 3). Disad-
vantages of this approach are the limited dissemina-
tion of the invention. It is as if in a village everybody
is trying to renovate his own house in his own way
without learning from each other. Eijkelberg showed in
Issue 2 an example of two diabetes projects that could
hardly be merged because the owners wanted to learn
from their own experiences only. Another disadvan-
tage is the amount of frustration when something goes
wrong or is not available. Once, a team invented a new
geriatric consultation point within a hospital for general
practitioners. Everything was well prepared. The only
thing that was lacking was GPs referring the older
patients. There was a good solution but no problem.
The second approach is RDI: research, development
and implementation. Here, the start is a description of
public health problems and a search for interesting
solutions in neighbouring sectors, in the past and else-
where in the health world. Once this is done, an inno-
vation is conceptualised and elaborated, and put in a
research design with control groups and, if to some
degree possible, with randomisation. The RDI
approach follows the principle of think first, do later,
and it has the support of everybody who loves Evi-
dence Based Medicine.
Disadvantages of RDI are that the real health care
world is not organised in this way. Innovators do not
read scientific literature to get ideas. They think faster
than they read. And researchers have difficulties
publishing their articles on innovations because mostly
the research design is weak. For instance the patient
series is too short. Or the control group is already
infected by the new innovation and shows a better out-
come as well. Or the innovating pioneer is so mission
driven and charismatic that it is unclear what the main
influencing factor is: the pioneer, the innovation or the
enthusiastic dedicated people within the project.
IJIC has, apart from the policy section, two main sec-
tions in its issues: one on research and theory and one
on projects and developments. In this way we try to
offer different platforms: one for researchers and one
for innovators. But, is this the right perspective for
the future? Is it possible to build a bridge between
researchers and innovators of integrated care? The
answer is yes, when a taxonomy of research and inno-
vation is available, like the phases I to IV of research
and development of pharmaceutical drugs. The lowest
phase of integrated care research shows the public
health problem and the direction of the integrated care
solutions. This research can be enough for redesign-
ing financial systems and health policy in such a way
that they stimulate the indicated solutions. An example
is the article of Japanese authors in this IJIC Issue.
They show how a change in the financing of long-term
care stimulates integrated care management. The sec-
ond phase in our taxonomy is not the testing of an
innovation as is done in the pharmaceutical world. It
is the inventory of already existing innovations. A cross
sectional, observational study and not one clinical trial
is here the indicated research method. By means of
multivariate analyses of many observed values or by
contrast group analyses with less observed values,
best practices can be filtered out. The third phase is a
qualitative study of best practices that came up in
the second phase. Meiss c.a. gave an example of this
type of research using a quality auditing method for a
research paper.
In these three phases research follows the develop-
ments in integration of care instead of leading them.
But the developments are described and published.
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invites their readers to submit these phase 2 and 3
articles. In the beginning of September the members
of the editorial board meet each other, not as is usual
by phone or by email but in reality. Maybe, we will
integrate our two platforms into one big theatre for
papers that discuss research as well as developments
in integrated care.
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